[Recent management of XXXX ].

@entity1 @entity2558 @entity1803 @entity5 @entity1358 @entity3
Our experience of radical nephrectomy was analyzed and recent management of @entity1358 was reviewed. One hundred forty-eight @entity1 with @entity1358 were treated by radical nephrectomy between 1970 and December, 1986. The 5-year survival rate according to pathological @entity5 was 100% for 4 @entity1 in @entity2558 , 73% for 85 @entity1 in pT2, 51% for 54 @entity1 in @entity1803 , and 0% for 5 @entity1 in pT4. Four @entity1 in @entity2558 had no venous involvement, lymph node @entity3 , or distant @entity3 . Thirty @entity1 had venous involvement, 8 in pT2, 20 in @entity1803 and 2 in pT4. Seventeen @entity1 had positive lymph nodes, 0 in pT2, 15 in @entity1803 and 2 in pT4. Thirty-three @entity1 had distant @entity3 at the time of nephrectomy, 12 in pT2, 18 in @entity1803 and 3 in pT4. The 5-year survival rates of 30 @entity1 with venous involvement, 17 with lymph node @entity3 and 33 with distant @entity3 were 47%, 30% and 37%, respectively. No anti- @entity5 drugs have been recognized to be effective for @entity1358 . However, recent experiences with interferon and lymphokine-activated killer cell therapy suggest that immunotherapy may have a potential role in the management of @entity1358 .
